Bibliography

Export 25 results:

Filters: Keyword is Cohort Studies [Clear All Filters]

2014

Josephson CD, Caliendo AM, Easley KA, Knezevic A, Shenvi N, Hinkes MT, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA pediatrics// Jama, Pediatr.. 2014;168(11):1054-62.

Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet//Lancet. 2014;384(9956):1766-73.

Yusen RD, Hong BA, Messersmith EE, Gillespie BW, Lopez BM, Brown KL, et al. Morbidity and mortality of live lung donation: results from the RELIVE study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2014;14(8):1846-52.

2011

Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion//Transfusion. 2011;51(8):1716-22.

2010

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, et al. Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol. 2010;48(6):785-91.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, et al. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010;89(1):69-74.

Kayler LK, Segev DL. The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization. Am J Kidney Dis. 2010;56(1):95-101.

Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101-11.

Saner FH, Gensicke J, Olde Damink SW, Pavlakovic G, Treckmann J, Dammann M, et al. Neurologic complications in adult living donor liver transplant patients: an underestimated factor? J Neurol. 2010;257(2):253-8.

Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091-100.

2009

Del Pozo JL, van de Beek D, Daly RC, Pulido JS, McGregor CG, Patel R. Incidence and clinical characteristics of ocular infections after heart transplantation: a retrospective cohort study. Clin Transplant. 2009;23(4):484-9.

Remeijer L, Duan R, van Dun JM, Wefers Bettink MA, Osterhaus AD, Verjans GM. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis. 2009;200(1):11-9.

Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15(10):5.

2008

Caner A, Döşkaya M, Karasu Z, Değirmenci A, Guy E, Kiliç M, et al. Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in Western Turkey. Liver Transpl. 2008;14(10):1526-32.

Patel S, Cassuto J, Orloff M, Tsoulfas G, Zand M, Kashyap R, et al. Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation. 2008;85(4):561-5.

Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8(12):2569-79.

2007

Taioli E, Mattucci DA, Palmieri S, Rizzato L, Caprio M, Costa AN. A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia. Transplantation. 2007;83(1):13-6.

2004

Pedotti P, Poli F, Longhi E, Frison S, Caldara R, Chiaramonte S, et al. Epidemiologic study on the origin of cancer after kidney transplantation. Transplantation. 2004;77(3):426-8.

2002

Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2002;118(4):1112-9.

2001

Kauffman HM, McBride MA, Delmonico FL. UNOS Transplant Tumor Registry: donors with a history of cancer. Transplant Proc. 2001;33(40575):1844-5.

1999

LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 1999;23(10):991-6.

Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.

1998

Lin HM, Kauffman HM, McBride MA, Davies DB, Rosendale JD, Smith CM, et al. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. Jama. 1998;280(13):1153-60.

1995

Harrison DA, Hodge DO, Bourne WM. Outcome of corneal grafting with donor tissue from eyes with primary choroidal melanomas. A retrospective cohort comparison. Arch Ophthalmol. 1995;113(6):753-6.

Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 1995;35(2):91-7.